Literature DB >> 8455914

Detection and quantitative analysis of joint activity inflammation with 99Tcm-polyclonal human immunoglobulin G.

F Pons1, F Moyá, R Herranz, M Solá, J A Del Olmo, C Piera, J Muñoz-Gómez, J Setoain.   

Abstract

99Tcm-polyclonal human immunoglobulin G (HIG) scintigraphy was used to detect active joint inflammation and to obtain ratios of joint uptake in noninvolved and inflammatory joints. Imaging was performed at 4 and 24 h in 16 patients with rheumatoid arthritis (RA) and 16 with degenerative joint disease (control group). All joints (total of 1344) were scored for pain, swelling and visual analysis of uptake in both scans. Joint to background (J:B) ratios were also calculated. Clinical and visual scores correlated in both scans (r = 0.7, P < 0.01). In RA patients, 246 joints were clinically involved. Visual analysis of scans detected 213 (87%) of them at 4 h and 196 (80%) at 24 h. Joints with no pain or swelling showed significantly higher J:B ratios than the control group and lower ratios than joints clinically involved. In the control group, statistically significant differences in J:B ratios between the various joints were found, so it was necessary to establish a normal range for every joint. J:B ratios were significantly higher at 4 h than at 24 h in both groups of patients. 99Tcm-HIG scintigraphy allows detection and measurement of joint inflammation. Scans performed at 4 h are preferable to scans at 24 h. Quantitative analysis can measure more objectively the degree of activity and could be useful in the management of these patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8455914     DOI: 10.1097/00006231-199303000-00013

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  6 in total

1.  Radionuclide imaging with human polyclonal immunoglobulin (Tc-HIG) and bone scan in patients with rheumatoid arthritis and serum-negative polyarthritis.

Authors:  G Gerasimou; E Moralidis; E Papanastasiou; G Liaros; T Aggelopoulou; E Triantafyllidou; N Lytras; L Settas; A Gotzamani-Psarrakou
Journal:  Hippokratia       Date:  2011-01       Impact factor: 0.471

2.  Technetium-99m labelling of human immunoglobulin and preliminary clinical evaluation in tumour patients.

Authors:  A D Varvarigou; S C Archimandritis; A Stripsanelli; A Arka; P Kostamis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Apr-Jun       Impact factor: 2.441

3.  Value of 99mTc-IgG scintigraphy in the prediction of joint destruction in patients with rheumatoid arthritis of recent onset.

Authors:  M H de Bois; M L Westedt; J W Arndt; K S Wiarda; E A van der Velde; E K Pauwels; F C Breedveld
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

Review 4.  New agents for scintigraphy in rheumatoid arthritis.

Authors:  M H de Bois; E K Pauwels; F C Breedveld
Journal:  Eur J Nucl Med       Date:  1995-11

5.  Tc-99m HIG Scintigraphy in Detection of Active Inflammation in Ankylosing Spondylitis.

Authors:  Ozhan Ozdoğan; Berna Değirmenci; Ozlem Senocak; Selmin Gülbahar; Gülhan Arslan; Cengiz Taşçı; Elif Akalın; Hatice Durak
Journal:  Mol Imaging Radionucl Ther       Date:  2011-08-01

6.  The Agreement Between Blood Pool - Delayed Bone Scintigraphy and Tc-99m Human Immunoglobulin G (HIG) Scintigraphy in the Determination of the Presence and Severity of Inflammatory Arthritis.

Authors:  Gulizar Kacar; Cahit Kacar; Firat Gungor
Journal:  Mol Imaging Radionucl Ther       Date:  2011-08-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.